Q4
LONG ANSWER
10M
★ High-yield
Describe the routes of spread of malignant tumours. Explain the metastatic cascade and the factors determining the site of metastasis.
Definition
Metastasis is the spread of tumour to a site physically discontinuous with the primary, and is the single most reliable criterion of malignancy.
- About 30% of patients have detectable metastases at presentation, and metastasis is responsible for the great majority of cancer deaths
- Exceptions that virtually never metastasise — basal cell carcinoma of the skin and most gliomas, though both are locally invasive and destructive
Routes of Spread
| Route | Favoured by | Examples |
|---|---|---|
| Local (direct) invasion | All malignant tumours | Infiltration of adjacent structures |
| Lymphatic | Carcinomas | Breast to axillary nodes; stomach to Virchow node; the pattern follows anatomical drainage, which is why sentinel node biopsy works |
| Haematogenous | Sarcomas (and some carcinomas — renal, thyroid, choriocarcinoma) | Veins are invaded more readily than arteries, being thin-walled; liver and lung are the commonest sites, being the first capillary beds encountered |
| Transcoelomic | Tumours reaching a serosal surface | Ovarian carcinoma seeding the peritoneum; gastric carcinoma to the ovary — the krukenberg tumour |
| Perineural | Along nerve sheaths | Adenoid cystic carcinoma; prostate; pancreas |
| Implantation (iatrogenic) | Along a needle or incision track | Rare but recognised after biopsy or surgery |
| Along epithelial-lined spaces | Bronchi, ureters, fallopian tubes | Renal pelvis to ureter |
CLINICAL PEARL
Lymphatic and haematogenous spread are not watertight categories. The two systems communicate freely, so carcinomas eventually reach the blood and sarcomas can involve nodes. The rule is a useful starting point for deciding what to stage, not a law — and nodal involvement in a sarcoma, though uncommon, carries a poor prognosis.
The Metastatic Cascade
- 1. Loss of adhesion — downregulation of E-cadherin loosens cells from one another → 2.
- Attachment to the basement membrane through laminin and fibronectin receptors → 3.
- Degradation of the basement membrane and matrix by matrix metalloproteinases and cathepsins → 4.
- Migration through the defect, guided by autocrine motility factors → 5.
- Intravasation into a vessel or lymphatic → 6.
- Survival in the circulation — most cells die
- platelet aggregation protects the survivors → 7.
- Arrest and extravasation at a distant site → 8.
- Formation of a micrometastasis, angiogenesis and growth
- The process is grossly inefficient — fewer than one in ten thousand circulating tumour cells forms a metastasis; the rate-limiting step is survival and growth at the new site, not escape from the primary
WHY Tumours Metastasise Where They Do
| Theory | Explanation | Evidence |
|---|---|---|
| Anatomical ("mechanical") | Cells lodge in the first capillary bed they meet | Colon → liver by the portal vein; most other tumours → lung |
| "seed and soil" (Paget) | Certain tumours grow only in a receptive tissue environment | Prostate → bone; breast → bone, brain and adrenal; and the striking RARITY of metastases in spleen and skeletal muscle despite their rich blood flow |
- The spleen and skeletal muscle are the argument for seed and soil — both receive abundant blood yet are almost never sites of metastasis, which no purely mechanical theory explains
- BATSON vertebral venous plexus — a valveless plexus connecting pelvic and vertebral veins, explaining why prostate carcinoma spreads to the lumbar vertebrae without passing through the lungs
Common Sites and Their Primaries
| Site of metastasis | Usual primaries |
|---|---|
| Liver | Colon, stomach, pancreas, lung, breast |
| Lung | Breast, colon, kidney, testis, sarcomas |
| Bone — osteolytic | Lung, kidney, thyroid, breast, myeloma |
| Bone — osteoblastic (sclerotic) | Prostate; also breast |
| Brain | Lung, breast, melanoma, kidney |
| Virchow node (left supraclavicular) | Stomach and other abdominal malignancy |
| Ovary (Krukenberg) | Stomach — signet-ring cells |
Local Invasion — the First Step
- Invasion precedes metastasis and is itself diagnostic of malignancy
- Malignant cells grow along the lines of least resistance — along fascial planes, perineural spaces and vessel walls
- Some tissues resist invasion — cartilage, elastic arteries and dense fascia are relatively resistant, which is why tumours often spread around rather than through them
- Basement membrane breach is the definitive event, and its demonstration is why histology beats cytology for diagnosis
| Tissue | Behaviour towards invasion |
|---|---|
| Loose connective tissue, fat, marrow | Invaded easily and early |
| Veins and lymphatics | Thin walls, readily invaded — the route to metastasis |
| Arteries | Relatively resistant — thick elastic and muscular walls |
| Cartilage | Highly resistant — avascular and rich in inhibitors of proteases and angiogenesis |
| Dense fascia and periosteum | Act as temporary barriers, directing spread laterally |
Applied Aspects
- Sentinel node biopsy identifies the first node draining a tumour; if it is clear, full nodal clearance and its morbidity can be avoided — standard in breast cancer and melanoma
- Metastasis of unknown primary — immunohistochemistry identifies the tissue of origin: cytokeratin for carcinoma, vimentin for sarcoma, S-100 and HMB-45 for melanoma, LCA for lymphoma
- Bone metastases present with pain, pathological fracture, hypercalcaemia or cord compression, and are best detected by isotope bone scan
- Solitary metastases may be resected with curative intent — liver metastases from colorectal cancer are the clearest example
- Staging determines treatment more than histology does, which is why so much effort goes into imaging before any decision is taken
- Anti-angiogenic and anti-metalloproteinase strategies target the cascade directly, though clinical results have been more modest than the biology promised
- Dormancy — micrometastases may remain undetectable for years and then grow, which is why breast cancer can recur two decades after apparently curative treatment
- Adjuvant chemotherapy after "curative" surgery exists precisely to destroy micrometastases that are already present but undetectable
- Circulating tumour cells can be counted in blood and correlate with prognosis, though most never establish a metastasis
- Handling a tumour gently at operation and ligating the venous drainage early are long-standing surgical principles founded on this biology
- The pattern of spread guides the operation — en bloc resection with the draining lymph nodes for carcinoma; wide local excision without nodal clearance for most sarcomas
- Bone metastases from prostate are characteristically osteoblastic, appearing dense on radiographs, whereas most others are lytic — a useful clue to the primary
All questions in Neoplasia
- Q1Define neoplasia. Describe the nomenclature of tumours and differentiate benign from malignant tumours. Add a note on anaplasia. ★
- Q2Describe the molecular basis of cancer. Discuss oncogenes, tumour suppressor genes and DNA repair genes with examples. ★
- Q3Classify carcinogenic agents. Describe chemical, radiation and viral carcinogenesis with examples. ★
- Q4Describe the routes of spread of malignant tumours. Explain the metastatic cascade and the factors determining the site of metastasis. ★
- Q5Describe the laboratory methods used in the diagnosis of cancer. Explain grading and staging and add a note on paraneoplastic syndromes. ★
- SN1Define dysplasia and carcinoma in situ. Describe their features and significance. ★
- SN2Define oncogenes. Describe the mechanisms of their activation with examples. ★
- SN3Describe the structure, function and significance of the p53 gene. ★
- SN4Describe the important tumour markers with their uses and limitations. ★
- SN5Describe tumour angiogenesis with its regulation and clinical significance. ★
- SN6Define teratoma. Classify teratomas and describe the ovarian mature cystic teratoma.
- SN7Describe the paraneoplastic syndromes with their mechanisms and associations. ★